Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Procuritas sells Lekolar AB to 3i Group
Mandate

Procuritas sells Lekolar AB to 3i Group

March 09, 2007

3i Group and funds managed by 3i have entered into an agreement to purchase Lekolar AB, which distributes educational products, learning materials and other items to schools and kindergartens. Lekolar, headquartered in Osby in southern Sweden, is present across the whole of the Nordic Region. The group includes Brio Lek & Lär AB in Sweden, Printel in Finland, Rabo in Denmark and Brio Lek & Lar in Norway.

Vinge acted as adviser to the vendor, Procuritas. Carl Gustaf De Geer, Hillevi Myhre, Daniel Rosvall and Nina Farrahi represented Vinge.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026